98%
921
2 minutes
20
Hypertensive (HTN) patients with type 2 diabetes mellitus (T2DM) are at an increased risk of adverse survival outcomes compared to non-diabetic individuals. This study aimed to retrospectively evaluate the prognostic significance of ambulatory blood pressure monitoring (ABPM) in a subgroup of diabetic patients. A total of 823 HTN patients, followed since 1994 at a hospital (follow-up: 11.8 ± 5.6 years), were included in the study. These patients underwent ABPM using a SpaceLabs 90207 device (SpaceLabs Healthcare, Snoqualmie, WA, USA) during a normal working day. Data from both the ABPM and office blood pressure (BP) values, as well as cardiovascular risk factors, were analysed. The patients were divided into two groups: diabetic (n = 240) and non-diabetic (n = 583). Data were analysed using IBM SPSS Statistics for Windows, Version 25 (Released 2017; IBM Corp., Armonk, NY, USA). Our study showed that HTN patients with T2DM experienced more severe cardiovascular events (χ² = 25.34, p < 0.001), heart failure (χ² = 27.7, p < 0.001), and mortality (χ² = 11.8, p < 0.01). Also, they had elevated pulse pressure (PP) values (analysed either as a continuous variable or using a 60-mmHg cut-off within ABPM values), which were associated with worse survival outcomes. In the analysis of HTN phenotypes, the presence of resistant hypertension (RH) was significantly higher in the diabetic group (χ² = 8.14, p < 0.05), which is associated with poorer survival. Despite the growing body of research, there are currently no studies in the literature using ABPM data specifically in diabetic patients. These data could offer valuable insights into the BP patterns of these patients, helping to define the most effective therapeutic strategies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11849757 | PMC |
http://dx.doi.org/10.7759/cureus.77974 | DOI Listing |
J Clin Invest
September 2025
Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, United Kingdom.
Understanding the genetic causes of diseases affecting pancreatic β cells and neurons can give insights into pathways essential for both cell types. Microcephaly, epilepsy and diabetes syndrome (MEDS) is a congenital disorder with two known aetiological genes, IER3IP1 and YIPF5. Both genes encode proteins involved in endoplasmic reticulum (ER) to Golgi trafficking.
View Article and Find Full Text PDFJ Clin Invest
September 2025
Department of Cellular and Molecular Medicine, UCSD, La Jolla, United States of America.
3-O-sulfation of heparan sulfate (HS) is the key determinant for binding and activation of Antithrombin III (AT). This interaction is the basis of heparin treatment to prevent thrombotic events and excess coagulation. Antithrombin-binding HS (HSAT) is expressed in human tissues, but is thought to be expressed in the subendothelial space, mast cells, and follicular fluid.
View Article and Find Full Text PDFJAMA Netw Open
September 2025
Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Importance: As obesity rates rise in the US, managing associated metabolic comorbidities presents a growing burden to the health care system. While bariatric surgery has shown promise in mitigating established metabolic conditions, no large studies have quantified the risk of developing major obesity-related comorbidities after bariatric surgery.
Objective: To identify common metabolic phenotypes for patients eligible for bariatric surgery and to estimate crude and adjusted incidence rates of additional metabolic comorbidities associated with bariatric surgery compared with weight management program (WMP) alone.
J Behav Med
September 2025
Center for Indigenous Health, Johns Hopkins University, Duluth, MN, USA.
Indigenous Peoples experience the highest age-adjusted prevalence of type 2 diabetes of any racial group in the U.S. Though the management of type 2 diabetes requires regular healthcare visits, North American Indigenous individuals with diabetes do not always utilize the healthcare available to them, and this lack of utilization may lead to poor health outcomes over time.
View Article and Find Full Text PDFDermatol Ther (Heidelb)
September 2025
Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Massarenti 9, 40138, Bologna, Bologna, Italy.
Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have gained prominence for their efficacy in treating type 2 diabetes and obesity. Recent evidence suggests that their pleiotropic effects-beyond glycemic control and weight loss-include anti-inflammatory, immunomodulatory, and antioxidative effects, which may beneficially support various dermatologic conditions such as psoriasis, hidradenitis suppurativa, acanthosis nigricans, and Hailey-Hailey disease. However, GLP-1 RAs are also associated with emerging cutaneous adverse drug reactions, including bullous, exanthematous and vasculitic manifestations, and other rare side effects.
View Article and Find Full Text PDF